Purchase Order 75N91020P00613
Award Date 8/4/20
Potential Completion Date 9/3/20
Potential Value $496K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $246,650.00 firm-fixed-price purchase order to Nanostring Technologies, Inc. for a GeoMx Digital Spatial Profiler (DSP) analysis instrument. The purpose is to support the Center for Immuno-Oncology's research into the tumor immune microenvironment, using the GeoMx DSP to perform spatial transcriptomics and proteomics on preclinical and clinical samples. The contract does not have a...
- This is a firm-fixed-price contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science research tools. The contract, valued at $8,832.00, was awarded by the National Cancer Institute, a component of the National Institutes of Health, and does not have a set-aside designation. Nanostring will provide the agency with its proprietary nCounter and GeoMx analysis systems, as well as associated reagents, assays, and testing...
- NanoString Technologies, Inc. received a federal contract award from the National Cancer Institute (NCI) on August 30, 2016, valued at $8,520.00 with a firm fixed price structure. This award was issued as a Blanket Purchase Agreement (BPA) call with an ultimate completion date of September 12, 2016 and was performed in Bethesda, Maryland. No set-aside designation was applied to this contract. NanoString Technologies is a provider of advanced genomic analysis platforms and life science tools,...
- Nanostring Technologies, Inc. has been awarded a $49,500 purchase order by the National Cancer Institute (NCI), a component of the Department of Health and Human Services' National Institutes of Health (HHS-NIH), to provide an upgrade to geomagnetic data signal processing (GEOMX DSP) software. The firm fixed price contract runs from September 2022 through March 2024 and will be performed in Potomac, Maryland. As the prime contractor, Nanostring will deliver upgraded software to support NCI's...
- This $149,050.00 firm fixed price purchase order contract was awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Nanostring Technologies, Inc., a publicly held provider of life science tools for translational research and molecular diagnostics. The contract provides a NanoString Life Sciences Digital Analyzer NCT-DIGA-LS instrument, which includes a trade-in for an existing instrument. Nanostring Technologies has...
- NanoString Technologies, Inc. received a $24,960 firm fixed price contract award from the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health, on August 16, 2016. This award was issued as a call against a blanket purchase agreement (BPA), with an ultimate completion date of August 21, 2016 and no set-aside designation. The work is to be performed in Bethesda, Maryland. NanoString is a publicly traded provider of advanced genomic analysis platforms and life...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a publicly held provider of life science tools, for HU V3 MIRNA REAGENTS. The contract has a potential value of $24,339.90 and a completion date of September 5, 2023. Nanostring Technologies has an extensive history of providing specialized laboratory equipment, consumables, and testing services to support genomic,...
- NanoString Technologies, Inc. received a $5,200 firm fixed price contract award from the National Institute of Environmental Health Sciences on August 24, 2017, with an ultimate completion date of September 24, 2017. This award was issued as a Blanket Purchase Agreement (BPA) call with no set-aside designation and represents performance services to be delivered in Seattle, Washington. NanoString is a publicly traded provider of advanced genomic analysis platforms and life science tools,...
- The National Cancer Institute awarded Nanostring Technologies, Inc. a $5,974.50 firm fixed price call against a blanket purchase agreement for biological materials, chemicals, and laboratory supplies on April 17, 2018. The contract, which was not set aside for small businesses, represents a delivery order for specialized genomic analysis consumables and reagents to support the National Cancer Institute's research initiatives. The work was completed by May 17, 2018, with performance taking...
- Nanostring Technologies, Inc. received a contract award from the National Cancer Institute (NCI) on September 5, 2017, for biological products under a Blanket Purchase Agreement (BPA) call. The firm fixed price contract, valued at $6,126.00, was completed by October 5, 2017, with performance conducted at the company's Seattle, Washington facility. No set-aside designation was applied to this award. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and...